ESX is an epithelial-restricted member of a large family of transcription factors known as the Ets family. ESX expression has been shown to be correlated with Her2/neu proto-oncogene amplification in highly aggressive breast cancers and induced by Her2/neu in breast cell lines, but its role in tumorigenesis is unknown. Previously, we have shown that ESX enhances breast cell survival in colonyformation assays. In order to determine whether ESX can act as a transforming gene, we stably transfected MCF-12A human mammary epithelial cells with the ESX expression vector, pCGN2-HA-ESX. The MCF-12A cell line is immortalized, but nontransformed, and importantly, these cells fail to express endogenous ESX protein.
Introduction
The ETS family is a large group of transcription factors that are known to play significant roles in development, differentiation and transformation (Graves and Petersen, 1998; Wasylyk et al., 1998) . ETS family members are defined by the ETS domain, a highly-conserved, 85 amino-acid DNA-binding domain (DBD) that is folded into a novel winged helix-turn-helix DNA-binding motif (Donaldson et al., 1994; Donaldson et al., 1996) . ESX, also known as ESE-1, Ert, Jen and Elf-3, is unique among ETS members with regards to its expression and its structure. Specifically, its expression is restricted to epithelial cells and the protein contains two additional motifs, a serine-rich box and an AT-hook domain Chang et al., 1997 Chang et al., , 1999 Oettgen et al., 1997) . The founding member of the ETS family, the vets oncogene from the E26 retrovirus, causes hematopoetic malignancies in chickens (Leprince et al., 1983 ). An important aspect of this family of transcription factors is that several ETS members have also been identified as critical components of the cellular pathways leading to tumorigenesis in humans (Dittmer and Nordheim, 1998; Wasylyk et al., 1998) .
Several different lines of evidence suggest that ETS factors play a particularly relevant role in breast cancer. For example, ETS factor overexpression has been reported in human and rodent mammary tumor biopsies and cell lines, including members of the ETS-1, PEA-3 and ESX genes (Baert et al., 1997; Benz et al., 1997; Gilles et al., 1997; Dittmer and Nordheim, 1998; Watabe et al., 1998; Shepherd and Hassell, 2000) . Moreover, expression of dominant-negative (dn) Ets DBD constructs has been shown to completely block the anchorage-independent growth and cellular invasiveness of MMT and BT20 breast carcinoma cell lines (Delannoy-Courdent et al., 1998; Sapi et al., 1998) . These results provide compelling data supporting a direct role of ETS proteins in transformation of mammary epithelial cells. Of these various ETS factors, ESX has been recently implicated as a key transcription factor associated with human breast cancer (Liu et al., 1992; Chang et al., 1997; Tymms et al., 1997) . For example, ESX has been shown to be amplified in B50% of early breast tumors (Tymms et al., 1997) and ESX expression is significantly increased in ductal carcinoma in situ (DCIS) (Liu et al., 1992; Chang et al., 1997) . Furthermore, there is a positive correlation between ESX and HER2/neu proto-oncogene expression in human breast cancers, and this coexpression strongly correlates with a highly metastatic phenotype and poor prognosis (Liu et al., 1992; Benz et al., 1997; Chang et al., 1997) . A positive-feedback-regulatory loop between HER2/neu and ESX has been suggested by the demonstration that HER2/neu activation induced ESX expression, while the Her2/neu promoter can be activated by ESX via an ETS-like DNA sequence motif O'Hagan and JA, 1998; Eckel et al., 2003) . While these studies clearly implicate ETS factors in breast cancer, the ability of any specific ETS factor, including ESX, to actually transform normal breast cells has not been shown.
To investigate the potential roles of ESX in breast cell transformation and acquisition of metastatic potential, we generated stable transfectants of MCF-12A human mammary epithelial cells expressing ESX, Ets-2 and V12-Ras. We chose MCF-12A cells as the model system, since these cells are immortalized, but nontransformed human mammary epithelial cells (Paine et al., 1992 ) that fail to express ESX (see below). In this paper, we focused on functional assays that measure cellular transformation and metastatic potential, with particular emphasis on examining the epithelial-to-mesenchymal transition (EMT). The rationale for this emphasis is that EMT has been strongly correlated with multiple events in the metastatic cascade, including the ability of tumor cells to disseminate from the primary tumor, to intravasate into vasculature or lymphatics, and to extravasate into tissue at secondary sites (Hay, 1995; Horwitz et al., 1995; Kantor and Zetter, 1996) . At the cellular level, EMT involves loss of epithelial characteristics, such as apical-basal cell polarity and cell-cell adhesion junctions, and gain of mesenchymal characteristics, such as motility and invasiveness; all attributes that are readily measurable in vitro (Kantor and Zetter, 1996) . Here, we show that stable expression of ESX is sufficient to confer a transformed and in vitro metastatic phenotype to otherwise normal, but immortalized MCF-12A cells, suggesting that ESX may be a critical downstream effector of the HER2/neu pathway.
Results

Characterization of the stable pooled cell lines
In order to test the hypothesis that ESX imparts a transformed phenotype upon human mammary epithelial cells, we required a human mammary epithelial cell line that displays essentially a nontransformed phenotype and that does not express ESX. The MCF-12A cell line fulfills these criteria. MCF-12A cells are a mixed population of epithelial cells that grow as patches of organized cuboidal cells surrounded by fibroblast-like cells in culture (Paine et al., 1992) . They are EGF dependent for proliferation, fail to grow in an anchorage-independent manner and fail to produce tumors in nude mice (Wang et al., 1997) . Although the parental MCF-12A cells used here displayed the mixed morphologies noted above, all cells were found to be both cytokeratin and vimentin positive by immunohistochemistry (data not shown). To verify that MCF-12A cells failed to express ESX, we performed reverse transcriptase-polymerase chain reaction (RT-PCR) analysis using oligonucleotide primers specific for the endogenous ESX mRNA in MCF-7 cells, as a positive control, and in MCF-12A cells (Figure 1a ). The results show that endogenous ESX is detected in MCF-7 cells with as few as 20 cycles, whereas no ESX RT-PCR Figure 1 Expression of ESX in wild-type MCF-12A and ESX-P cells. (a) MCF-12A cells fail to express ESX mRNA. RT-PCR products of total RNA derived from MCF-7 (lanes 1-4) and MCF-12A (lanes 5-8) human breast cells, using ESX-specific primers, were submitted to 1% agarose gel electrophoresis. Samples were removed after 20 (lanes 1 and 5), 25 (lanes 2 and 6), 30 (lanes 3 and 7) and 35 (lanes 4 and 8) PCR cycles. DNA size markers are indicated on the left. The expected ESX band of 1.1 kb is indicated by an arrow and primer-dimer (p2) band. (b) RT-PCR analysis of HA-ESX expression in MCF-12A stable pools. RT-PCR was performed on RNA isolated from ESX-P, Ets-2-P and V12-Ras-P stable pools, as described in Materials and methods. In all, 25 cycles of PCR were carried out using oligonucleotides primers specific for exogenous HA-ESX. The PCR products were loaded onto a 1% agarose gel, electrophoresed and stained with ethidium bromide. Lane 1: H 2 O-only control; lane 2: minus RT; lane 3: MCF12-A; lane 4: pCGN2-P; lane 5: ESX-P; lane 6: Ets-2-P; lane 7: V12-Ras-P and lane 8: pCGN2-HA-ESX plasmid as positive control product was detected in MCF-12A cells with as many as 35 cycles (Figure 1a) .
Having verified that MCF-12A cells do not express ESX, these cells were stably transfected with pCGN2-HA-ESX to evaluate the effects of ESX expression on mammary cell transformation. As a positive control for transformation, we used pSV-Ras, which encodes the V12Ras oncogene and has been shown to confer the transformed phenotype in MCF-12A cells (Wang et al., 1997) . In addition, overexpression of the ETS family member, Ets-2, has been correlated with mammary tumorigenesis, but its precise role remains in question (Neznanov et al., 1999) . Thus, we used pCGN2-HA-Ets-2, which encodes an HA-tagged version of Ets-2, to compare its effects with those of ESX and V12-Ras. The pCGN2 control vector, pCGN2-HA-ESX, pCGN2-HA-Ets-2 or pSV-Ras plasmid DNAs were individually transfected into MCF-12A cells. Stable transfectants were selected and approximately 200 stably transfected clones were pooled to establish pooled cell lines denoted as pCGN2-P, ESX-P, Ets-2-P and V12-Ras-P. We chose to focus our study on pooled, stable transfectants, rather than clonal isolates, since the parental MCF-12A population is morphologically heterogenous and this heterogeneity appears to contribute to the normal, nontransformed phenotype (Paine et al., 1992; Kordon and Smith, 1998) .
To verify the expression of exogenous HA-ESX in the stable ESX-P cells, we performed RT-PCR analysis using oligonucleotide primers specific for the HA-tagged ESX cDNA. Figure 1b , lanes 1 and 2 show two negative controls, demonstrating that neither the solutions of the PCR or reverse trancriptase (RT) reactions contained HA-ESX mRNA or DNA contaminants, respectively. Lanes 3 and 4 ( Figure 1b) show that neither nontransfected parental MCF-12A cells or vector control pCGN2-P cells, respectively, express detectable levels of HA-ESX mRNA. By contrast, HA-ESX mRNA was readily detected in ESX-P cells (Figure 1b, lane 5) . DNA sequencing of the upper, dominant band verified that the product was indeed authentic HA-ESX (data not shown). Also, Figure 1b , lanes 6 and 7, reveal that Ets-2-P and V12-Ras-P cell lines failed to express HA-ESX mRNA. In addition, we verified that exogenous HAEts-2 was expressed in the Ets-2-P cells using a similar RT-PCR strategy (data not shown). Finally, lane 8 shows the PCR product of a positive control, using pCGN-ESX plasmid DNA as the PCR template.
ESX, Ets-2 and V12Ras confer EGF-independent growth
The parental MCF-12A cells have been reported to be highly dependent on exogenous EGF for cell growth (Paine et al., 1992) . One characteristic of cellular transformation is loss of growth factor dependence (Hanahan and Weinberg, 2000) . In order to evaluate the EGF dependence of pCGN2-P, ESX-P, Ets-2-P and V12-Ras-P cells for growth, we determined the growth rates of each of these cell populations in media containing reduced serum (1% horse serum) in the presence or absence of EGF (20 ng/ml). As shown in Figure 2a , the parental nontransfected MCF-12A and the pCGN2-P cells had a limited ability to grow in media that lacked EGF, whereas cell number of ESX-P, Ets-2-P and V12-Ras-P cells increased fourfold relative to parental or pCGN2-P controls by day 6. Indeed, by the fifth day, the number of cells in control cultures was declining, while the cell number in ESX-P, Ets-2-P and V12-Ras-P cultures continued to increase. The differences in cell number between control and experimental lines is unlikely to be attributed to differential plating efficiency, since the number of adhered cells 24 h after initial plating of these various cell lines was statistically indistinguishable from each other (Figure 2a, 1 day) . However, the ESX-P, Ets-2-P and V12-Ras-P cells respond to exogenous EGF as demonstrated by a fivefold increase in cell number in EGF-containing media (Figure 2b ) compared to EGF-depleted media ( Figure 2a) . Therefore, transfection of ESX, Ets-2 or V12-Ras did not confer a significant growth advantage when cells were plated in EGF-containing media. Cumulatively, these data indicate that stable expression of ESX, Ets-2 and V12-Ras imparts a survival advantage to MCF-12A cells under EGF-depleted conditions, rather than conferring a dominant proliferative advantage, since there is a difference in the absolute cell number achieved7EGF.
Phosphorylated levels of MAP kinase in stable populations
Having shown that ESX-P, Ets-2-P and V12-Ras-P cells had a growth advantage in EGF-depleted media (Figure 2a) , we hypothesized that an autocrine loop had been established in MCF-12A cells by the expression of ESX, Ets-2 and V12-Ras. If this was the case, then downstream signaling molecules, such as MAP kinase, should be in the active, phosphorylated state even in the absence of EGF and serum. To determine the levels of phosphorylated MAP kinase in pCGN2-P, ESX-P, Ets-2-P and V12-Ras-P cells, these lines were grown in serum-depleted (0.1%) media lacking EGF. Under these growth conditions, the untransfected MCF-12A and vector control pCGN2-P cells displayed little to no detectable levels of phosphorylated MAP kinase (Figure 2c ). In contrast, in these serum-starved and growth factor-depleted conditions, the ESX-P, Ets-2-P and V12-Ras-P cells displayed readily detectable levels of phosphorylated MAP kinase. The data in Figure 2c was quantitated by densitometry and normalized to the actin levels, and revealed that phospho-MAPK levels were equivalent for the ESX-P and Ets-2-P cells and that these levels were approximately 20-fold greater than that of vector control cells (data not shown). Of note, the V12-Ras-P cells displayed a 200-fold increase in phospho-MAPK levels compared to controls cells (data not shown). These data are consistent with the cell number data (Figure 2a) , and suggest that ESX, Ets-2 and V12-Ras have each established an autocrine loop, resulting in constitutive phosphorylation of MAPK in cells under growth-restrictive conditions.
Anchorage-independent growth of ESX-P, Ets-2-P and V12-Ras-P cells in soft agar
The transfection of constitutively active Ras into WT MCF-12A cells has been shown to give these cells the ability to form colonies in soft agar (Wang et al., 1997) . Such anchorage-independent growth is an accepted indicator of transformation (Hanahan and Weinberg, 2000) . In order to assess the transformation potential of HA-ESX and HA-Ets-2 in MCF-12A cells, the ability of stable pooled populations of cells to form colonies in the restrictive soft agar assay was determined. At 4 weeks, vector control plates had very few detectable colonies (Figure 3 , pCGN2-P). HA-ESX transfectants had numerous small (0.1 mm) to medium (0.6 mm) foci (Figure 3 , ESX-P). HA-Ets-2 and V12-Ras stable cells had fewer, but larger foci ranging from 0.5 to 2 mm, which were easily detectable with the naked eye ( Figure 3 , Ets-2-P andV12Ras-P).
ESX, Ets-2 and V12Ras confer a functional mesenchymal phenotype in MCF-12A cells A hallmark characteristic of highly metastatic epithelial tumor cells is the acquisition of motility and invasiveness, functional attributes of a mesenchymal phenotype (Hay, 1995) . In order to determine whether ESX, Ets-2 Figure 3 Colony-formation assay of stable pCGN2-P, ESX-P, Ets-2-P and V12Ras-P cells in soft agar. A total of 2 Â 10 4 cells from each cell line were plated in soft agar. Representative photographs taken at 4 weeks show colonies or the lack thereof for pCGN2 control vector (upper left), HA-ESX (upper right)-, HA-Ets-2 (lower left)-and V12Ras (lower right)-transfected stable cell lines. Size bar equals 2 mm Figure 2 ESX-P, Ets-2-P and V12Ras-P cells demonstrate enhanced EGF-independent cell growth. Cell growth of wild-type and pCGN2-P, ESX-P, Ets-2-P and V12Ras-P stable cell lines were determined in media containing reduced serum (1% horse serum) (a) in the absence of EGF or (b) in the presence of 20 ng/ml EGF (lower panel). Cells were plated at an initial density of 10 000 cells per plate. At 24-h intervals, cells were harvested from plates and manually counted in triplicate using a hemocytometer, for a total of 5 days. Data represent mean cell counts7s.e.m. (c) ESX-P, Ets-2-P and V12Ras-P stable cell lines exhibit elevated levels of activated p44/42 MAP kinase in the absence of EGF. Wild-type and pCGN2-P, ESX-P, Ets-2-P and V12Ras-P stable cell lines were serum-starved for 12 h in media containing 0.1% horse serum and lacking EGF. Cell lysates were prepared from wild-type MCF-12A cells (lane 1), vector-only stable cells (lane 2) and stable cell lines expressing either HA-ESX (lane 3), HA-Ets-2 (lane 4) or V12-Ras (lane 5). Equal amounts of total cellular protein were electrophoresed on 10% PAGE and analysed by Western blot. Upper panel depicts a representative Western blot probed with an antibody specific for phosphorylated p44/42 MAPK (pMAPK). Lower panel depicts the same Western blot stripped and reprobed with an antibody against b-actin (Actin), to control for loading differences between samples or V12-Ras are able to induce a functional EMT in MCF-12A cells, we measured their adhesive, motile and invasive properties. Figure 4 shows that 75 min after initial plating, B25% of pCGN-2-P control cells were adhered, while B70% of the ESX-P and Ets-2-P cells were adhered. The V12-Ras-P cells adhered more rapidly (50% at the earliest time point of 30 min) and more completely (essentially 100% by 45 min). At 24 h after plating, the plating efficiency was equivalent for all cell lines (data not shown), an observation consistent with data presented in Figure 2 .
Having established increased adhesiveness of the ESX-P, Ets-2-P and V12-Ras-P cells, we next evaluated whether these cells also displayed increased motility. In the scrape motility assay, confluent cultures were wounded by scraping cells to expose a linear cell-free zone. The cell motility that is measured in the scrape assay relies on the ability of cells to overcome cell-cell and cell-substratum interactions. In the culture conditions used here, we minimized the contribution of cell proliferation to the repopulation of the scrape zone by utilizing serum-free and growth factor-depleted media. The ability of cells to repopulate this zone was measured 24 h after wounding ( Figure 5a ). In serum-free culture conditions, pCGN2-P cells failed to repopulate this zone ( Figure 5a , upper left), while ESX-P and Ets-2-P cells repopulated approximately 50% of the scraped zone ( Figure 5a , upper right and lower left). The V12-Ras-P cells displayed the highest motility and were able to repopulate the entire zone within 24 h ( Figure 5a , lower right).
Visual inspection of the scrape zone revealed notable differences in cell morphology between the cell lines. The pCGN2-P cells produced two distinct morphological phenotypes, a densely packed, darkly stained cuboidal-like epithelial cell that formed distinct islands ( Figure 5a , upper left, wide arrows) and more loosely packed, lightly stained elongated cells that surrounded these islands (fine arrow). These two distinct cell phenotypes have been previously described for MCF-12A cells (Paine et al., 1992) . Remarkably, in the ESX-P, Ets-2-P and V12-Ras-P cells there is a selective loss of the cuboidal islands, while the fibroblast-like cells were maintained ( Figure 5a ). Of note, the V12-Ras-P cells acquired additional morphological features, manifested by a higher degree of homogeneity and a particularly elongated cell shape.
To gain further insights of the motile properties gained by ESX expression, we also tested MCF-12A cell motility using the short-term (4 h) transwell assay, wherein the ability of single cells to migrate independent of cell interactions and in response to a chemoattractant is measured. As shown in Figure 5b , the pCGN2-P vector control cells displayed very low motility (B12 cells/field; set to 1), while the ESX-P cells revealed approximately 6.5-fold increased motility (B80 cells/ field). The Ets-2-P cells (B48 cell/field) also demonstrated a fourfold increased motility compared to control pCGN2-P cells, but an apparent reduced motility compared to ESX-P cells. The V12-Ras-P cells showed the highest motility (B150 cells/field; 11.5-fold). Thus, using two different experimental approaches to measure cell motility, we detected an increased motility in the ESX-P, Ets-2-P and V12-Ras-P cells in comparison to control pCGN2-P cells. Analysis of cell morphology in the transwell assay revealed that the ESX-P and ETS-2-P cells had very different cell shape compared to the V12-Ras-P cells. Figure 5c shows representative fields of the bottom of transwell filters, stained with crystal violet. The upper left panel shows that very few pCGN2-P cells migrated through the filter. The arrow points to a filter pore, and a single stained motile cell is noted just above and to the left of the arrow. The ESX-P panel shows numerous migratory cells, and these cells acquired a flattened morphology with increased surface area and prominent broad lamellapodia (arrow). Panel Ets-2-P depicts cells with both large ruffled lamellopodia (arrow) and occasional thin filopodia. In contrast, the morphology of the V12Ras-P cells was highly elongated and fibroblast-like, with two to three prominent filopodia per cell (arrow).
Having established that the ESX, Ets-2 and V12-Ras genes conferred a motile phenotype to MCF-12A cells, we next sought to determine whether these various stable cell lines displayed enhanced invasive properties. The method used to test for invasion was the transwell filter 24 h invasion assay. In this assay, cells are overlayed onto filters in which the 8 mm pores are occluded with gelatin so that the transit of cells to the lower chamber requires both active matrix degradation and motility. Figure 5d shows that, independent of media conditions, control pCGN2-P cells displayed low invasion (B40-50 cells/field), while the ESX-P, Ets-2-P and V12Ras-P displayed marked invasion that ranged from three to sixfold over controls (Figure 5d ). These results, demonstrating invasiveness in the absence of Figure 4 Cell adhesion is altered in ESX-P, Ets-2-P and V12Ras-P cells. Ability of cells to adhere to plastic substratum was measured over a 75 min time course. Adherent cells were stained with 0.1% crystal violet and the dye was extracted with ethanol. Adherent cell number was quantified by determining optical absorbance at 590 nm. Bars represent % adherent cells at the indicated time points after initial plating. Experimental conditions were performed in triplicate and data are expressed as mean7s.e.m. ESX-P, Ets-2-P and V12Ras-P cells revealed significantly increased adherence at 75 min postplating compared to vector control cells, Po0.008, 0.001 and 0.006, respectively (two-tailed t-test) growth factors are in agreement with our previous data showing that the ESX-P, Ets-2-P and V12Ras-P cells are able to proliferate and activate MAPK in growth factordepleted conditions and are consistent with the idea that an autocrine loop has been established by the expression of ESX, Ets-2 or V12Ras.
MCF-12A cells recapitulate normal mammary development in a three-dimensional (3D) culture assay
We sought to expand the utility of the MCF-12A cell system by establishing a 3D culture assay designed to mimic normal mammary development in vitro. Our rationale for this approach was that 3D assays have been demonstrated to rapidly distinguish between transformed and nontransformed mammary epithelial cells in culture (Weaver et al., 1996) . For our studies, we sought to determine the effects of ETS transcription factors and oncogenic V12Ras on the ability of MCF-12A cells to develop into mammary duct-like structures. In order to address this question, we first needed to establish whether MCF-12A cells were capable of recapitulating normal mammary gland-like structures in 3D culture. Single-cell suspensions of MCF-12A cells were overlayed onto reconstituted basement membrane substratum (Matrigel s ) and organoid development was Figure 5 Increased cell motility in ESX-P, Ets-2-P and V12Ras-P cells. (a) Cell motility was increased in ESX-P, Ets-2-P and V12Ras-P cells in the scrape assay. Cells in 2-D culture were wounded by scraping confluent monolayers. The ability of the cells to repopulate the scrape zone in the presence of media devoid of serum and growth factors was determined after 24 h. pCGN2-P (upper left panel), ESX-P cells (upper right panel), Ets-2P cells (lower left panel) and V12Ras-P cells (lower right panel). The pCGN2-P cell monolayer consisted of two distinct cell populations (upper left), fine arrow depicts elongated fibroblast-like cells and wide arrows depict dense, epithelial like colonies. Experimental conditions were performed in triplicate, experiment in duplicate. Representative data are shown. Size bar equals 100 mm. (b) Migration of cells through Boyden chamber filters was increased in ESX-P, Ets-2-P and V12Ras-P cells. Filters with 8 mm pores were coated with 10 mg/ml gelatin. Cells were plated in upper wells of chambers using 0.5% horse serum as a chemoattractant in lower wells. Cell motility was measured as a function of the number of cells that traversed from the upper chamber to lower chamber within 4 h. Data are expressed as mean7s.e.m. ESX-P, Ets-2-P, and V12Ras-P cells displayed significantly higher motility than pCGN2-P control cells, Po0.0001 for all three cell lines (two-tailed t test). While Figure 5b depicts a representative experiment performed in triplicate, the same trends in motility observed for the ESX-P, Ets-2-P and V12-Ras-P cells were reproducibly obtained in three separate experiments. (c). Motile ESX-P and Ets-2-P cells predominantly display lamellopodia, while V12Ras cells display filopodia. Cells that traversed the 8 mm filter in the transwell filter motility assay were stained with 0.1% crystal violet and representative areas were photographed. Upper left panel shows a single migratory CGN2-P cell and numerous empty 8 mm filter pores (pore denoted by arrow). Actively motile ESX-P cells (upper right panel) displayed prominent lamellopodia (arrow). Motile Ets-2-P cells (lower left panel), displayed both ruffled lamellopodia (arrow) and filopodia, while motile V12Ras-P cells (lower right panel) displayed prominent filopodia (arrow). Size bar equals 50 mm. (d). Invasion through modified Boyden chamber filters is increased in ESX-P, Ets-2-P and V12Ras-P cells. Filter pores (8 mm) were occluded with 200 mg/ml gelatin. Cells were plated in upper wells of chambers using 0.5% horse serum as a chemoattractant in lower wells. Cell transit from upper chamber to lower chamber requires degradation of gelatin within pores. Cell invasion was measured as the number of cells that traversed through filter pores within 24 h. Data are expressed as mean7s.e.m. ESX-P, Ets-2-P, and V12Ras-P cells displayed significantly higher invasiveness than pCGN2-P control cells, Po0.0001 for all three cell lines (two-tailed t test). The invasion results of the four stable cell lines in serum-free and EGFfree culture medium, either in the presence (moderately restrictive media) or absence (highly restrictive media) of insulin, hydrocortisone and cholera toxin analysed, as previously described (Bemis and Schedin, 2000) . Within the first 24 h, MCF-12A cells were observed to aggregate into solid 3D mammary-like structures (data not shown). Between 24 and 72 h, these organoids hollowed into both alveolar-and duct-like organoids with central lumens, as shown in Figure 6a , left panels. An alveolar-like structure is depicted in the upper left panel with the asterisks denoting cavitation and the arrow pointing to an apoptotic cell. In comparison to parental MCF12A cells, the pCGN2-P cells organized only into duct-like structures (Figure 6a , right panels). In addition, fewer of these pCGN2-P organoids hollowed (Figure 6a, upper right panel) . However, both the parental MCF-12A and pCGN2-P cells maintained several features of normal mammarylike epithelium, including morphological evidence of lumen formation, apical-basal polarity, cell-cell adhesions, organoid size (i.e. organoids that approximate in vivo duct and alveolar size) and lack of invasiveness into surrounding matrix. Surprisingly, the parental MCF-12A and pCGN2-P duct-like organoids were composed of cells displaying both cytokeratin and vimentin IHC staining (data not shown), demonstrating that under these conditions vimentin-expressing cells can contribute to polarized epithelium.
ESX-P, Ets-2-P and V12Ras-P cells form aggressive tumor-like structures in 3D culture
Having established that MCF-12A and control pCGN2-P cells were capable of forming normal mammary glandlike structures in 3D cultures, we next determined the Figure 6 Wild-type MCF-12A cells form mammary-like organoids in 3D culture, while ESX-P, Ets-2-P and V12Ras-P cells form tumor-like structures displaying a functional EMT. (a) MCF-12A and pCGN-2-P cells recapitulate aspects of mammary gland development in 3D culture. MCF-12A and vector control pCGN2-P cells were overlaid onto thick, reconstituted EHS basement membrane as single-cell suspensions. Single-cell aggregation into organoids was monitored for 72 h and organoids were processed for 5 mm histological sections and stained with hematoxylin and eosin. Left three panels depict typical organoid morphologies observed with MCF-12A cells. Upper left panel shows an alveolar-like structure with hollowed lumen (asterisks) and evidence of an internal apoptotic cell (arrow), Â 400. Middle left panel shows hollowed duct-like organoid, Â 400 and lower left panel shows high magnification view of a duct-like structure demonstrating morphological evidence of cell polarity, cell-cell junctions and an apoptotic cell within the lumen (arrow), Â 1000. Right three panels depict typical organoid morphologies observed with vector control pCGN-2-P cells. Upper right panel shows duct-like structure with partial cavitation, Â 400. Middle right panel shows hollowed duct-like structure, Â 400 and lower right panel shows high magnification view of duct-like structure, Â 1000. Size bar in Â 400 photos equals 25 mm and in Â 1000 photos equals 10 mm. (b) ESX-P, Ets-2-P and V12Ras-P cells form solid tumor-like structures and fail to organize into mammary gland-like structures in 3D culture. ESX-P, Ets-2-P and V12Ras-P cells were cultured and processed as described in Figure 6a . Top panel and three left panels depict typical solid tumor-like organoids formed by ESX-P, Ets-2-P and V12Ras-P cells at 24 h, respectively, Â 400. Right three panels show evidence of EMT in ESX-P, Ets-2-P and V12Ras-P cells at periphery of organoids after 72 h in culture. Arrowheads identify invasive, fibroblast-like cells that penetrate into surrounding matrices. Size bar in Â 400 photos equals 25 mm and in Â 1000 photos equals 10 mm ability of ESX-P, Ets-2-P and V12Ras-P cell lines to organize in 3D culture. All three of these cell lines formed disorganized solid structures consistent with an aggressive, tumor-like phenotype (Figure 6b) . Within the first 24 h, the ESX-P, Ets-2-P and V12Ras-P cell lines formed large, solid organoids that lacked cell polarity and failed to hollow, because unlike parental MCF-12A cells, internal cells failed to die (Figure 6b , top and left three panels). Failure of internal cells to undergo apoptosis is further evidence that ESX-P, Ets-2-P and V12Ras-P cells are anchorage-independent for cell viability. Moreover, many of the tumor-like organoids formed by these cell lines were much larger than those formed by the parental and pCGN-2P cells (compare top panel of Figure 6b to 6a). This result indicates that these tumor-like organoids failed to appropriately limit the number of cells contributing to each organoid, an attribute previously identified in tumorigenic mammary epithelial cells in 3D culture (Weaver et al., 1996) . By 72 h, the ESX-P, Ets-2-P and V12Ras-P organoids exhibited features not seen in control organoids. Specifically, cells from the ESX-P, Ets-2-P and V12Ras-P organoids had locally invaded their surrounding matrix (Figure 6b , right three panels, arrowheads). In addition to acquisition of motility and invasiveness, these invasive cells displayed further evidence of EMT, as shown by their loss of adhesion to neighboring cells and acquisition of fibroblast-like shape with prominent invasive filopodia (Figure 6b , arrowheads).
Having demonstrated a functional EMT in the ESX-P, Ets-2-P and V12Ras-P cells, we further characterized the EMT phenotype using an antibody against cadherin to detect alterations in epithelium-specific adherens junctions (Hay, 1995) . As expected, pCGN-2-P organoids displayed distinct cadherin staining localized at cell-cell interfaces (Figure 7a, upper left) . In contrast, the ESX-P, Ets-2-P and V12Ras-P organoids showed a total disruption of junctional cadherin complexes, as demonstrated by a diffuse cytoplasmic cadherin staining pattern (Figure 7a ). Further, in comparison to pCGN2-P organoids, cytokeratin staining was also reduced in ESX-P, Ets-2-P and V12Ras-P organoids (Figure 7b ), whereas vimentin staining remained unchanged (data not shown). Cumulatively, these immunohistochemical studies demonstrate that loss of cytokeratin and disruption of cadherin, correlates with loss of epithelial cell polarity and tumorigenic attributes in MCF-12A cells more specifically than loss of vimentin.
ESX-P, Ets-2-P and V12Ras-P cells have reduced proliferation rates in 3D culture
As shown in Figure 2 , we have demonstrated that the ESX-P, Ets-2-P and V12Ras-P cells have a survival advantage in EGF-depleted media. Since the 3D culture conditions more closely mimic the in vivo cell-cell and cell-substratum architecture, we sought to determine the effects of ESX, Ets-2 and V12Ras gene expression on the proliferation rates of these cells in the 3D culture model. Contrary to our expectations, morphological analysis of 5 mm sections of organoids revealed decreases bromodeoxyuridine (BrdU) incorporation in ESX-P, Ets-2-P and V12Ras-P cells, compared to control pCGN-2-P cells (Figure 8a ). In the pCGN-2-P cells, BrDU incorporation was preferentially localized to those cells at the periphery of the organoid (Figure 8a , upper left Figure 7 Adherens junctions and cytokeratins are lost in ESX-P, Ets-2-P, and V12Ras-P organoids. pCGN2, ESX-P, Ets-2-P, and V12Ras-P cells were plated as single-cell suspensions onto reconstituted basement membrane. After 72 h in culture, organoids were harvested and processed to 5 mm sections. (a) Adherens junctions were visualized by immunohistochemical detection of cadherin protein. Left panel depicts the typical compacted cuboidal epithelium observed with pCGN2-P cells. Well-delineated cadherin staining is evident at the plasma membrane junctions between the pCGN2 cells. Immunohistochemical detection of cadherin in ESX-P (upper right), Ets-2-P (lower left) and V12Ras-P (lower right) organoids demonstrate that strong adherens junctional staining is lost and that cadherin staining is diffuse and cytoplasmic. (b) Immunohistochemical detection of cytokeratins in pCGN2-P cells (left panel) shows strong cytoplasmic cytokeratin staining. In contrast, the majority of cells in the ESX-P (upper right), Ets-2-P (lower left) and V12Ras-P (lower right) organoids are negative for cytokeratin staining. Size bars equal 25 mm panel, arrow), indicating that proliferation occurred in cells contacting the matrix substratum. By contrast, BrDU incorporation in the ESX-P (upper right panel), Ets-2-P (lower left panel) and V12Ras-P (lower right panel) cells was scattered and random throughout the solid tumor-like lesion (large arrows). Of interest, ESX-P, Ets-2-P and V12Ras-P cells that displayed the EMT phenotype and that had migrated away from the central solid tumor, were not observed to incorporate BrDU (Figure 8a, arrowheads) . Quantitation of BrDU incorporation revealed that ESX-P, Ets-2-P and V12Ras-P cells displayed proliferation rates that were B5-6-fold lower compared to that of the pCGN-2-P control cells (Figure 8b) . Specifically, in a 24 h period, 32% of the pCGN-2-P cells displayed proliferation (Figure 8b ),whereas the percent of ESX-P, Ets-2-P and V12Ras-P cells that incorporated BrDU was much lower, measuring 5, 8 and 13%, respectively (Figure 8b ).
Discussion
This paper provides several key contributions that further our understanding of transformation of mammary epithelial cells by Ets factors. Importantly, this is the first demonstration of the ability of transfected Ets DNA to act as a transforming gene in mammary epithelial cells in vitro. Here, we show that the Ets factors ESX and Ets-2 are each capable of conferring aggressive, metastatic properties to immortalized, but nontumorigenic human mammary epithelial MCF-12A cells. Specifically, ESX and Ets-2 stably transfected MCF-12A cells acquired growth factor-and anchorageindependent growth, and displayed enhanced motility and invasiveness in 2D and 3D culture. Moreover, in 3D organoid assays, it was evident that ESX and Ets-2 induced a functional EMT, similar to that induced by oncogenic V12Ras. Interestingly, while we identified a growth advantage to the ESX-P, Ets-2-P and V12Ras-P cells in 2D culture in growth-restrictive conditions, these same cells had significantly reduced proliferative capacity in 3D culture. This observation suggests that the cell microenvironment may regulate a switch between mitosis and cell motility in transformed MCF-12A cells, an observation that may have potential clinical significance. Specifically, in vivo, metastatic breast cancer cells reside in a milieu similar to the 3D culture conditions, and thus may be relatively hypoproliferative and resistant to chemotherapeutic agents targeting rapidly dividing cells.
Ets factors, particularly Ets-1, Ets-2 and Pea-3, have been implicated in mammary tumorigenesis (Baert et al., 1997; Benz et al., 1997; Gilles et al., 1997; Dittmer and Nordheim, 1998; Watabe et al., 1998; Shepherd and Hassell, 2000; Shepherd et al., 2001; Span et al., 2002) . Recently, RNA overexpression of another Ets factor, PSE/PDEF, initially identified in prostate, has been shown to be a marker for metastatic breast cancer (Ghadersohi and Sood, 2001; Mitas et al., 2002) . The most definitive reports to date demonstrate that loss of Figure 8 BrdU incorporation into pCGN2-P, ESX-P, Ets-2-P and V12Ras-P cells in 3D culture. (a) Immunohistochemical detection of BrdU of pCGN2-P, ESX-P, Ets-2-P and V12Ras-P cells in 3D culture. pCGN2-P, ESX-P, Ets-2-P and V12Ras-P cells were overlaid onto thick reconstituted basement membrane as single-cell suspensions. After 72 h in culture, cells were treated with 1 mM BrdU for 24 h. pCGN2-P cells (upper left) form numerous small duct-like structures (asterisk) with frequent brown staining, BrdUpositive cells (arrow). ESX-P (upper right), Ets-2-P (lower, left) and V12Ras-P (lower right) cells form disorganized, solid tumor-like organoids with few BrdU-positive cells (arrows). Invasive cells are observed to penetrate surrounding matrices (arrowheads). Experimental conditions were each performed in quadruplicate, and the entire experiment in duplicate. Size bar equals 25 mm. (b) Quantitation of BrdU incorporation. Proliferative index was determining by quantifying BrdU incorporation between 72 and 96 h postplating, as described in Materials and methods. Experimental conditions were each performed in quadruplicate, and entire experiment in duplicate. Data are expressed as mean percentage of positive cells 7s.e.m. ESX-P, Ets-2-P and V12Ras-P statistically different from vector control cells, Po0.01, Poisson regression, adjusted for multiple comparisons Ets factor function suppresses both mammary tumor cell transformation and tumor formation. Expression of a dn Ets construct in several mammary epithelial tumor cell lines resulted in reversion of anchorage-independent cell growth and cellular invasiveness in vitro (DelannoyCourdent et al., 1998; Sapi et al., 1998) . In addition, bitransgenic ets-2 knockout/MMTV-PyMT mice displayed reduced mammary tumor progression (Neznanov et al., 1999) and bitransgenic pea3 knockout/ MMTV-neu mice revealed delayed mammary tumor onset and reduced multiplicity (Shepherd et al., 2001) .
ESX is an ETS transcription factor family member that may be particularly relevant in breast cancer due to its epithelial-specific mode of expression. ESX maps to human chromosome 1q32.1 in a region that is amplified in up to 50% of early-stage breast cancers and in DCIS. In addition, ESX RNA is overexpressed in human breast cancer Tymms et al., 1997) . Similarly, we have identified increased ESX expression in chemically induced rat mammary tumors (data not shown). We previously reported that ESX-nonexpressing MCF-12A cells, transiently transfected with an ESX expression vector, formed significantly more colonies than transfected control cells (Eckel et al., 2003) . Conversely, transient transfection of either an antisense or dn ESX construct into ESX-positive T47D cells resulted in considerable reduction in colony formation of these cells (Eckel et al., 2003) . The data presented here corroborate and extend our previous findings and show that ESX and Ets-2 expression is sufficient to transform immortalized MCF-12A mammary epithelial cells to a highly aggressive, transformed phenotype. Of note, stable expression of Pea-3 in MCF-12A cells failed to impart a transformed phenotype (Prescott JD and Gutierrez-Hartmann A, unpublished data), suggesting specificity of ESX and Ets-2 transformation effects.
Oncogenic cell transformation is correlated with growth factor independence, often due to establishment of autocrine loops that constitutively activate the MAPK pathway. For example, oncogenic Ras has been shown to establish EGF-related autocrine loop pathways by inducing TGF-alpha, amphiregulin and HB-EGF (Falco et al., 1990; Gangarosa et al., 1997) . Here, we show that the ability of ESX, Ets-2 and V12-Ras to confer EGF-independent growth to MCF-12A cells correlates with constitutive activation of MAPK (Figure 2c) . Notably, ESX, Ets-2 and V12-Ras were unable to confer the full mitogenic effects of exogenous EGF. One interpretation of these data is that EGF activates pleiotropic growth and survival pathways in MCF12-A cells, whereas ESX, Ets-2 or V12Ras may be activating a more restrictive response. Alternatively, EGF may activate the MAPK pathway transiently; whereas ESX, Ets-2 and V12-Ras activate MAPK persistently, which subsequently dampens the growth response. This type of differential proliferative response to transient vs persistent MAPK activation has been previously reported (Traverse et al., 1994) .
While growth factor independence is a key event in early stages of cellular transformation, a hallmark of overt metastasis is the transition of a tumor cell from an epithelial to a mesenchymal phenotype. During embryonic development, conversions between epithelium and mesenchyme occur regularly to allow for morphogenesis (Cunha, 1994; Hay, 1995) . However, in normal adult tissue, EMT occurs only in epithelial cells during pathological wound healing and metastasis (Hay, 1995) . Here, we have determined that ESX, Ets-2 and V12Ras induce functional attributes of EMT in MCF-12A cells.
In this study, functional EMT phenotypes of adhesion, motility and invasion were identified by multiple methodological approaches. The property of altered adhesion was directly detected by increased adhesion in the 90 min adhesion assay, and indirectly inferred by the ability of ESX-P, Ets-2-P and V12Ras-P cells to grow in soft agar independent of cell-cell contacts. Additionally, we observed formation of solid tumor-like organoids in the 3D assay. This is a significant observation because nontransformed mammary epithelial cells undergo cell death when contacts with basement membrane proteins are lost (Li et al., 1987; Blum et al., 1989; Boudreau et al., 1995) , resulting in the formation of hollow ductlike structures (Coucouvanis and Martin, 1995; Humphreys et al., 1996) . By contrast, the ability of ESX-P, Ets-2-P and V12Ras-P cells to form solid 3D structures demonstrates a loss of this cell adhesion requirement. Previously published reports have shown that Ets factors regulate key adhesion molecules, such as integrins and cadherins (Gilles et al., 1997; Takaoka et al., 1998; Oda et al., 1999; Rodrigo et al., 1999) . Consistent with this interpretation, we also show that cadherin-containing adherens junctions are disrupted in the ESX-P, Ets-2-P and V12-Ras-P organoids and cytokeratin staining is reduced (Figure 7) .
The observed changes in adhesive properties in the ESX-P, Ets-2-P and V12-Ras-P cells are predictive of increased motility. Indeed, increased motility in the ESX-P, Ets-2-P and V12-Ras-P cells was detected by three independent assays: scrape-injury, transwell filter migration and 3D organoid development. In support of our observations that gain of Ets function induces motility, expression of dn Ets-1 in murine MMT mammary tumor cell line resulted in inhibition of cell motility and enhancement of cell adhesion as measured by loss of cell scattering (Delannoy-Courdent et al., 1998) . Similarly, expression of a dn Ets-2 in human BT20 breast cancer cell line resulted in a loss of motility (Sapi et al., 1998) . Consistent with the motile phenotype, the ESX-P, Ets-2-P and V12-Ras-P cells, but not control cells, showed formation of broad lamellipodia and filopodia, prominent membrane protrusions at the leading edge of motile cells (Figure 5c ) (Lauffenburger and Horwitz, 1996; Stossel et al., 1999) . Of note, ESX-P and Ets-2-P showed formation of lamellopodia, whereas motile V12-Ras-P cells showed primarily filopodia formation (Figure 5c ). These distinct motile phenotypes suggest that Ets factors activate a different motility pathway than V12Ras. Candidate regulators of lamellipodia and filopdia are members of the Rho family of small GTPases; Rho, Rac and Cdc42 (Bar- Sagi and Hall, 2000) . Specifically, activation of Rac has been shown to induce lamellipodia, implicating Rac as a downstream effector of both ESX and Ets-2 Ets transcription factors in MCF12A cells.
In order for breast tumor cells to invade local tissue and gain access to the lymphatics and circulatory systems, they must be able to clear a path through extracellular matrix barriers (Basset et al., 1993; Benaud et al., 1998; Duffy et al., 1999) . Evidence for acquisition of an invasive phenotype in ESX-P, Ets-2-P and V12-Ras-P cells was generated using two distinct assays. In the transwell filter invasion assay, filter pores were occluded with gelatin so that secretion of gelatinase by ESX-P, Ets-2-P and V12-Ras-P cells was required for invasiveness (Figure 5d ). In the 3D organoid assay, invasiveness of ESX-P, Ets-2-P and V12-Ras-P cells was measured by the ability of cells to disseminate from the primary organoids and invade into surrounding reconstituted basement membrane (Figure 6b ). Of relevance to our observation that ESX and Ets-2 increase invasiveness of MCF12A cells, the Ets proteins Ets-1, ER81, PEA3 and E1AF have been shown to regulate a repertoire of genes that govern invasiveness in epithelial and mesenchymal cells, including collagenase, urokinase, matrylysin, and MT1-MMP (Shepherd and Hassell, 2000) . Taken together, these data reveal a step-wise progression in tumor-like organoid development, manifested by the initial formation of large, solid 3D structures that have lost adherens junctions and have reduced cytokeratin protein, failure of internal cells to die, followed by the formation of a peripheral zone of migrating and invasive cells.
Finally, we provide evidence that in the physiologically relevant environment of the 3D culture on reconstituted basement membrane, transformed MCF-12A cells significantly downregulate mitosis in comparison to nontransformed cells. In addition, cells that had undergone an EMT were not observed to synthesize DNA, implying that a switch between mitogenesis and motogenesis occurs in 3D culture. Suppression of mitosis in epithelial cells that have undergone an EMT has been previously reported. Rat bladder carcinoma NBT-II cells transition to a mesenchymal phenotype when treated with acidic fibroblast growth factor (aFGF) (Savagner et al., 1994) . When NBT-II cells are simultaneously treated with aFGF and growth media, these cells failed to incorporate 3H-thymidine. Furthermore, in the scrape-wounding assay, NBT-II cells located at the edge of the wound underwent EMT and did not synthesize DNA, whereas confluent cells within the monolayer synthesized DNA. More recently, it has been demonstrated that FGF can stimulate cell movement in all phases of the cell cycle except G2 and M, further supporting a role for a molecular switch between mitosis and motility (Bonneton et al., 1999) . Our observation that ESX-P, Ets-2-P and V12Ras-P cells are preferentially motogenic in 3D culture may have clinical impact. Specifically, tumorigenic cells that have undergone an EMT may be particularly resistant to standard chemotherapeutic drugs that target actively dividing cells.
Materials and methods
Plasmid constructs
A cDNA spanning the coding sequence of human ESX mRNA was amplified by RT-PCR and subcloned into pCR2.1 (Invitrogen Corporation), as previously described (Eckel et al., 2003) . The ESX cDNA sequence and its orientation were verified by dideoxy sequencing at the UCHSC Cancer Center DNA Sequencing Core facility. ESX was excised from pCR2.1-ESX by digestion with BglII and AflIII, and the 1116 base pair BglII ESX fragment was ligated into a BamHI linearized and dephosphorylated pCGN2-HA vector (Bradford et al., 2000) to generate pCGN2-HA-ESX (Eckel et al., 2003) . The plasmid pCGN-HA-Ets-2 was provided by Dr Michael Ostrowski (Ohio State University).
Cell line culture conditions
MCF-12A cells were obtained from ATCC (Manassas, VA, USA). For routine maintenance, cells were grown in complete media consisting of Ham's F12/Dulbecco's modified Eagle's media (DMEMF12; Gibco/BRL) containing 100 ng/ml cholera toxin (Gibco/BRL), 0.5 mg/ml hydrocortisone (Sigma), 10 mg/ml insulin (Sigma), 20 ng/ml EGF (Sigma) and 5% horse serum (Gibco/BRL).
RT-PCR-MCF-7, MCF-12A wild-type, pCGN2-P, ESX-P, Ets-2-P and V12Ras-P cells were grown to 80-90% confluency and harvested with 1 Â PBS and 3 mM EDTA. Total RNA was isolated using an RNA STAT-60 kit (Teltest, Friendswood, TX, USA). Expression of endogenous ESX was determined using oligos specific for the 5 0 and 3 0 ends of the ESX coding region (Eckel et al., 2003) . Similarly, expression of HA-ESX mRNA was determined using oligos directed to the HA tag and the carboxy-terminus of ESX (Eckel et al., 2003) , thus allowing the selective amplification of the exogenous, recombinant HA-ESX mRNA.
Stable cell lines
Immortalized but nontransformed MCF-12A human mammary epithelial cells were transfected by electroporation with 2 mg of pRSVneo and either 20 mg of control pCGN2 vector, pCGN2-HA-ESX, pCGN2-HA-Ets-2 or pSV-Ras (oncogenic V12-Ras). Following electroporation, cells were immediately plated into 60 mm dishes with 3 ml of complete media, as described above. After a 24 h incubation in 95% O 2 and 5% CO 2 at 371C, media was replaced with fresh Ham's F12/ DMEM containing all of the supplements listed above, as well as 500 mg/ml G418 in order to select for geneticin-resistant cells. After 2 weeks of selection, pools of G418-resistant cells, denoted as pCGN2-P, ESX-P, Ets-2-P and V12Ras-P, were replated, expanded and maintained in complete media containing 200 mg/ml G418. For experiments described, log phase cells between passages 4-10 were utilized.
Phospho-MAP kinase assays
Stable cell lines were starved for 16 h in media containing 0.1% serum and no EGF. Cells were then harvested by lysis directly on the plate with 2 Â SDS protein load dye (Owl Separation Systems) consisting of 0.25 M Tris/HCl pH 6.8, 2% SDS, 10% b-mercaptoethanol, 30% glycerol and 0.01% bromophenol blue. Lysates were sheared with a 25G needle and boiled for 5 min before loading onto a 10% SDS polyacrylamide gel and analysed with a phospho-p44/42 MAP kinase antibody (New England Biolabs) by Western blot.
Cell growth assay
Cells were harvested from subconfluent plates and were resuspended in complete media and plated in 24-well plates at a density of 10 000 cells per well. After 24 h, cells were harvested from the first plate and counted on a hemocytometer. The medium was changed on the remaining cells to F12/DMEM with reduced serum (1%) and no EGF, or medium with reduced serum (1%) and the addition of 20 ng/ml EGF. This restricted medium was replaced on cells every 24 h in order to prevent growth factor accumulation from neighboring cells. Cells were harvested every 24 h for 5 days and cell number was determined by counting on a hemocytometer.
Soft agar assay Stable pools were harvested at 80-90% confluency and counted. A base layer of 0.35% low melting point agarose (SeaPlaque) in 1 Â DME (Gibco/BRL) and 10% horse serum (Gibco/BRL) was poured into 60 mm plates and allowed to harden at 41C. In all, 20 000 cells of each stable cell line were resuspended in complete media plus agar mixture at 421C and seeded on top of the solidified base layer. Plates were incubated at 371C in 95% O 2 and 5% CO 2 for 4 weeks. Plates were fed drop-wise with complete media as needed, to keep the agar mixture from drying out. After 4 weeks, plates were photographed at Â 40 for maximal colony visibility.
Adhesion assay
Log phase cells were harvested with trypsin-EDTA and resuspended at 60 000 cells per well in 96-well tissue culture plates (Nunclon) in complete medium supplemented with G418 (200 mg/ml). After 30, 45, 60 and 75 min of incubation at 371C, cells were rinsed 3 Â with Hank's buffered salt solution (HBSS) to remove nonadhered cells. Adhered cells were fixed with 10% neutral buffered formalin (NBF) for 5 min, stained with 0.1% crystal violet for 5 min, rinsed twice with HBSS to remove any unabsorbed stain, and air-dried. The number of adhered cells was determined using an optical density method previously described (Bernhardt et al., 1992) , with slight modifications. Briefly, crystal violet was extracted from stained cells by adding 180 ml of 70% ethanol per well, followed by rocking at RT for 2 h. Optical density of the extracted crystal violet was read at 590 nm. Each cell line and each time point were performed in quadruplicate. Data are expressed as mean7s.e.m. For determination of percent cells adhered, a standard linear curve was generated by measuring the optical density of extracted crystal violet from known cell concentrations.
Scrape assay
Log phase cells were placed in 60 mm tissue culture plates and grown to 100% confluency in complete medium supplemented with G418. The plates were rinsed in HBSS and a line of cells was removed from the center of the plates using a 1000 ml pipet tip. Free-floating cells, dislodged from the scrape line, were removed by rinsing with HBSS. Culture medium free of serum and EGF was added and plates incubated for 24 h at 371C. To visualize motile cells within the scrape line, cells were fixed with 10% NBF for 5 min, stained with 0.1% crystal violet for 5 min, and excess stain was removed with water. Cells were viewed on a Zeiss Axioscope 25 microscope and representative scrape lines for each cell line photographed. All conditions were performed in triplicate, and experiment in duplicate.
Transwell filter motility assay
Transwell tissue culture filters with 8.0 mm pore size (Falcon #3097) were precoated with 50 ml of 10 mg/ml porcine gelatin (Sigma), which was allowed to solidify overnight at room temperature. Log phase cells were harvested with trypsin-EDTA and resuspended in complete medium supplemented with only 0.1% horse serum. In all, 50 000 cells per well were overlaid onto the top of the transwell filters (24-well format). Cells were stimulated to migrate across the filters by providing a chemoattractant (0.5% horse serum) in the assay chambers beneath the coated filter. After a 4 h incubation at 371C, cells were fixed in 10% NBF for 5 min and stained with 0.1% crystal violet for 5 min. Nonmotile cells on the top of the filter were removed by gentle scraping and cells that crossed through the filter pores were quantified photographically as previously reported (Bemis and Schedin, 2000) . All conditions were performed in triplicate, and experimentin duplicate. Data are expressed as mean7s.e.m.
Invasion assay
Transwell filters were coated with 50 ml of 200 mg/ml porcine gelatin (Sigma) and allowed to solidify overnight to occlude the 8.0 mm pores. Cells were suspended at 50 000 cells per well in 24-well filter plates (Falcon) using two different culture media, designed to evaluate growth factor dependency of invasion. The least restrictive media contained Ham's F12/ DMEM (Gibco/BRL) supplemented with 0.1% horse serum, 10 mg/ml insulin, 500 ng/ml hydrocortisone, 20 ng/ml EGF, 100 ng/ml cholera toxin and 200 mg/ml G418. The highly restrictive media consisted of Ham's F12/DMEM without any supplementation. Horse serum (0.5%) was utilized as the chemoattractant in the lower chamber. The number of invasive cells, evaluated 24 h after plating, was quantified as for motility assay. All conditions were performed in triplicate, and experiment in duplicate. Data are expressed as mean7s.e.m.
3D culture model
Log phase cells in complete medium plus G418 were overlaid as a single-cell suspension onto a 100 ml matrix substratum using 30 000 cells per well (96-well tissue culture plate; Nunclon). The matrix substratum consisted of a 1 : 1 mixture of Matrigel (Collaborative Biomedics) and complete medium plus G418. The development of organoids in this 3D model is dependent on the migration of single cells into cell aggregates as previously described (Bemis and Schedin, 2000) . Organoid development was monitored over 96 h by inverted-light microscopy (Zeiss Axioscope 25) and photographed with a Polaroid camera at Â 100. After 72 h, the organoids were treated with 0.01 mM of BrdU (Sigma) for 24 h. Organoids were harvested at 96 h postplating, stained with 0.1% trypan blue, fixed in methacarn for 10 min, paraffin embedded, and cut into 5 mm sections.
Immunohistochemical detection of BrdU, pan cadherin and cytokeratin
Slides with 5 mm sections were heat fixed for 20 min at 801C. After clearing in xylene, tissue sections were rehydrated and endogenous peroxidase activity was blocked with 3% peroxide. For cadherin and cytokeratin detection, slides were pretreated by boiling slides in 10 mM sodium citrate buffer pH 6.0 for 20 min and blocked with 2% goat serum followed by incubation in a 1 : 400 dilution of either rabbit polyclonal antipan cadherin (Zymed) for 1 h or anti-pan cytokeratin (Ventana) for 3 h. For BrdU detection, pretreated slides were incubated in a 1 : 40 dilution of anti-BrdU (Beckton Dickinson) in PBS for 1 h followed by incubation in a 1 : 200 dilution of biotinylated rabbit anti-mouse secondary antibody (Dako) in PBS for 30 min. Biotin was detected by incubation in a 1 : 400-1 : 1000 dilution of a conjugated HRP-strepavidin (Dako), followed by 10 min of Stable DAB (Invitrogen). All slides were counterstained using a 1 : 10 dilution of Harris hematoxylin. The percentage of cells that incorporated BrdU was determined as previously described . Briefly, 20 randomly chosen fields were selected per cell line and photographed. The percent of BrdU-positive cells that stained dark-brown were counted from coded photographs independently by two investigators. BrdU data are expressed as mean7s.e.m.
